Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 374Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Smart & Biggar

02 1Takeda Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Febuxostat

Brand Name : ULORIC

Patent Number : 2566652

Filing Date : 1999-06-18

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-18

Date Granted : 2008-10-21

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Febuxostat

Brand Name : ULORIC

Patent Number : 2073981

Filing Date : 1991-11-29

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-29

Date Granted : 2002-01-08

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Febuxostat

Brand Name : ULORIC

Patent Number : 2301863

Filing Date : 1999-06-18

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-18

Date Granted : 2009-01-27

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Febuxostat

Brand Name : ULORIC

Patent Number : 2474674

Filing Date : 2003-03-28

Strength per Unit : 80 mg

Dosage Form : Tablet, Immediate Release

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-03-28

Date Granted : 2011-04-19

blank